Home | Business News | Browse by Publication | P | Pharma Marketletter

New data show Merck Sharp and Dohme's Cozaar to be cost-effective.

Publication: Pharma Marketletter
Publication Date: 28-JUN-04
Format: Online
Delivery: Immediate Online Access
Full Article Title: New data show Merck Sharp and Dohme's Cozaar to be cost-effective.(Brief Article)

Article Excerpt
Data presented at the European Society of Hypertension...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Vicuron to reduce costs due to anidulaflungin delay.(Brief Article), June 28, 2004
Basilea promotes Rienk Pypstra to chief development officer.(Brief Art..., June 28, 2004
Zafiris Zafirelis named CEO of Biopure.(Brief Article), June 28, 2004
Ranbaxy debuts chewable cephalosporin tab.(Brief Article), June 28, 2004
PTC Therapeutics closes $50M private placement.(Brief Article), June 28, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.